Initial experience with tissue plasminogen activator in two pediatric oncology patients

Journal of Intensive Care Medicine

Volumn 15, Issue 1, 2000, Pages 53-58

  Johnson, Tiffanie R ^a   Tobias, Joseph D ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILDHOOD CANCER; DEEP VEIN THROMBOSIS; ECHOCARDIOGRAPHY; FEMALE; FEVER; HEART ATRIUM THROMBOSIS; HUMAN; MALE; NEUROBLASTOMA; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SUPERIOR CAVA VEIN SYNDROME; T CELL LYMPHOMA; VOMITING;

EID: 0033979216     PISSN: 08850666     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1489.2000.00053.x     Document Type: Article

References (20)

1. Martinez-Tallo E, Campo R, Delgado M, et al. Thrombus in right atrium in two infants successfully treated with tissue plasminogen activator. Pediatr Emerg Care 1997;13:37-39
2. Andrew M, Michelson AD, Bovill E, et al. Guidelines for antithrombotic therapy in pediatric patients. J Pediatr 1998; 132:575-588
3. Bell SG. Recombinant tissue plasminogen activator. Neonatal Network 1996;15:13-18
4. David M, Andrew M. Venous thromboembolic complications in children. J Pediatr 1993;123:337-346
5. Anderson BJ, Keeley SR, Johnson ND. Caval thrombolysis in neonates using low doses of recombinant human tissue-type plasminogen activator. Anaest Intensive Care 1991;19:22-27
6. Dillon PW, Fox PS, Berg CJ, et al. Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy. J Pediatr Surg 1993;28:1264-1269
7. Ahluwalia JS, Kelsall AWR, Diederich S, et al. Successful treatment of aortic thrombosis after umbilical catheterization with tissue plasminogen activator. Acta Paediatr 1994;83: 1215-1217
8. Turpie AGG, Levine MN, Hirsh J, et al. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Chest 1990;97:S172-S175
9. Risius B, Graor RA, Geisinger MA, et al. Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts. Radiology 1986;160: 183-188
10. Holden RW. Plasminogen activators: pharmacology and therapy. Radiology 1990;174:993-1001
11. Ryan CA, Andrew M. Failure of thrombolytic therapy in four children with extensive thromboses. Am J Dis Child 1992; 146:187-193
12. Haire WD. Pharmacology of fibrinolysis. Chest 1992;101: S91-S97
13. Nightingale SL. From the food and drug administration. JAMA 1999;281:786
14. Petaja J, Peltola K. Venous thrombosis in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 1997;11:889-894
15. Levy M, Benson LN, Burrows PE, et al. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991;118:467-472
16. Leaker M, Massicotte MP, Brooker LA, et al. Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost 1996;76:132-134
17. Rodenhuis S, van't Hek LGFM, Vlasveld LT, et al. Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator. Thorax 1993;48:558-559
18. Wacker P, Oberhansli I, Didier D,et al. Right atrial thrombosis associated with central venous catheters in children with cancer. Med Pediatr Oncol 1994;22:53-57
19. Kennedy LA, Drummond WH, Knight ME, et al. Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator. J Pediatr 1990;116:798-801
20. Tobin JR, Tobias JD. Experience with urokinase in paediatric cardiology patients. Clin Intensive Care 1991;2:359-362